期刊： HYPERTENSION, 2022; 79 (12)
Background: Overproduction of endothelial extracellular vesicles (eEVs) is correlated with pulmonary hypertension progression, but the precise mechani......
期刊： HYPERTENSION, 2022; 79 (11)
Background: The causal links between urinary uromodulin (uUMOD) and cardiovascular disease (CVD) are still not clarified. Methods: We first assessed t......
期刊： HYPERTENSION, 2022; 79 (11)
Background: The association between changes in cardiovascular health score (CHS) over time and myocardial infarction (MI) risk in hypertensive patient......
期刊： HYPERTENSION, 2022; 79 (10)
Background: To provide tacrolimus is first-line treatment after liver and kidney transplantation. However, hypertension and nephrotoxicity are common ......
期刊： HYPERTENSION, 2022; 79 (10)
Background: Previous studies found that antihypertensive medications (AHMs) acting on the renin-angiotensin system had the potential to reduce the pro......
期刊： HYPERTENSION, 2022; 79 (11)
Background: Existing evidence indicates that elevated triglycerides may affect blood pressure, but the underlying mechanisms are not fully understood.......
期刊： HYPERTENSION, 2022; 79 (7)
Background: Pulmonary arterial hypertension is an incurable disease, in which the extracellular CaSR (calcium sensing receptor) is mechanistically imp......
期刊： HYPERTENSION, 2022; 79 (3)
Background: Endothelial dysfunction enhances vascular inflammation, which initiates pulmonary arterial hypertension (PAH) pathogenesis, further induce......
期刊： HYPERTENSION, 2022; 79 (8)
Background: Omics data may provide a unique opportunity to discover dairy-related biomarkers and their linked cardiovascular health. Methods: Dairy-re......
期刊： HYPERTENSION, 2022; 79 (12)
Background: Preeclampsia is a pregnancy syndrome that may utilize multiple pathogenic mechanisms. Insufficient trophoblast invasion and impaired uteri......
期刊： HYPERTENSION, 2022; 79 (6)
Background: Vascular smooth muscle cell (VSMC) phenotype transition plays an essential role in vascular remodeling. PGD(2) (Prostaglandin D-2) is invo......
期刊： HYPERTENSION, 2022; 79 (10)
BACKGROUND: Poorly controlled hypertension is a great challenge to global public health. Incentive approaches, based on behavioral and economic concep......
期刊： HYPERTENSION, 2022; 79 (5)
Background: Metabolic reprogramming is a hallmark of pulmonary arterial hypertension. Platelet activation has been implicated in pulmonary arterial hy......
期刊： HYPERTENSION, 2022; 79 (7)
Background: Mounting experimental evidence supports the concept that the RAAS (renin-angiotensin-aldosterone system) is involved in the pathogenesis o......
